Clinical Trial

Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]-INCB123667 in Healthy Male Participants

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This study will assess the mass balance, pharmacokinetics, and metabolite profiles of a single oral dose of \[14C\] INCB123667 in healthy male participants.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-10-16; most recent amendment 2026-01-06.
Status change: Recruiting → Completed 2026-01-06
Status change: Not Yet Recruiting → Recruiting 2025-10-24
Trial Details
NCT Number NCT07218744
Lead Sponsor Incyte Corporation
Conditions Healthy Participants
Enrollment 9 participants
Start Date 2025-11-13
Primary Completion 2025-12-10 (estimated)
Study Completion 2025-12-10 (estimated)
Updated on ClinicalTrials.gov 2026-01-07